Influence of probucol on enhanced LDL oxidation after fish oil treatment of hypertriglyceridemic patients

Arterioscler Thromb. 1993 Dec;13(12):1790-7. doi: 10.1161/01.atv.13.12.1790.

Abstract

The susceptibility of low-density lipoprotein (LDL) to oxidation was studied in hypertriglyceridemic men (5 with type III and 5 with type IV) at baseline on a low-saturated-fat, low-cholesterol diet, after 6 weeks of dietary supplementation with fish oil (Promega, 12 g/d), and after 6 weeks of fish oil combined with probucol (500 mg BID). The relative content of n-3 polyunsaturated fatty acids in plasma and LDL was increased during the two treatment periods, and a low alpha-tocopherol to n-3 polyunsaturated fatty acids ratio was observed. Plasma thiobarbituric acid-reactive substances (TBARS) levels were unchanged after 6 weeks of fish oil, but the ratio of lipid peroxides to the reduced triglyceride (TG) levels (MDA:TG) was significantly higher (P < .01). Addition of probucol lowered both absolute levels of TBARS (P < .01) and the MDA to TG ratio (P < .001). The susceptibility of LDL to Cu(2+)-catalyzed oxidation was evaluated over a 5-hour time course by determining TBARS formation, free amino group levels, and changes in LDL electrophoretic mobility. TBARS levels that were higher in native LDL (1.019 < d < 1.050 g/mL) after 6 weeks of fish oil than at baseline (P < .01) were reduced 52.3 +/- 11.3% by the addition of probucol (P < .001). With fish oil alone, TBARS production after exposure of LDL to Cu2+ for 5 hours was increased 17.0 +/- 5.8% compared with corresponding baseline values (P < .001), whereas a 64.1 +/- 14.3% reduction from the previous period was observed with fish oil + probucol (P < .001).(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antioxidants
  • Cholesterol, HDL / blood
  • Cholesterol, VLDL / blood
  • Copper / metabolism
  • Fish Oils / administration & dosage
  • Fish Oils / therapeutic use*
  • Humans
  • Hyperlipoproteinemia Type III / blood*
  • Hyperlipoproteinemia Type III / diet therapy
  • Hyperlipoproteinemia Type III / drug therapy
  • Hyperlipoproteinemia Type IV / blood*
  • Hyperlipoproteinemia Type IV / diet therapy
  • Hyperlipoproteinemia Type IV / drug therapy
  • Lipid Peroxidation / drug effects*
  • Lipoproteins, LDL / blood*
  • Lipoproteins, VLDL / blood
  • Male
  • Middle Aged
  • Probucol / administration & dosage
  • Probucol / therapeutic use*
  • Thiobarbituric Acid Reactive Substances / metabolism
  • Triglycerides / blood
  • Vitamin E / blood

Substances

  • Antioxidants
  • Cholesterol, HDL
  • Cholesterol, VLDL
  • Fish Oils
  • Lipoproteins, LDL
  • Lipoproteins, VLDL
  • Thiobarbituric Acid Reactive Substances
  • Triglycerides
  • very low density lipoprotein triglyceride
  • Vitamin E
  • Copper
  • Probucol
  • cupric chloride